| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | D-ribulose-phosphate 3-epimerase activity | 9.49e-06 | 2 | 62 | 2 | GO:0004750 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.88e-05 | 17 | 62 | 3 | GO:0046703 | |
| GeneOntologyMolecularFunction | racemase and epimerase activity, acting on carbohydrates and derivatives | 5.12e-04 | 11 | 62 | 2 | GO:0016857 | |
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 5.12e-04 | 11 | 62 | 2 | GO:0004143 | |
| GeneOntologyBiologicalProcess | positive regulation of type II interferon production | 5.39e-07 | 103 | 60 | 6 | GO:0032729 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate biosynthetic process | 9.23e-07 | 61 | 60 | 5 | GO:0034030 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate biosynthetic process | 9.23e-07 | 61 | 60 | 5 | GO:0034033 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate biosynthetic process | 9.23e-07 | 61 | 60 | 5 | GO:0033866 | |
| GeneOntologyBiologicalProcess | cellular response to dsRNA | 1.26e-06 | 28 | 60 | 4 | GO:0071359 | |
| GeneOntologyBiologicalProcess | susceptibility to natural killer cell mediated cytotoxicity | 1.94e-06 | 9 | 60 | 3 | GO:0042271 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell activation | 3.17e-06 | 35 | 60 | 4 | GO:0032816 | |
| GeneOntologyBiologicalProcess | regulation of type II interferon production | 5.85e-06 | 155 | 60 | 6 | GO:0032649 | |
| GeneOntologyBiologicalProcess | type II interferon production | 9.61e-06 | 169 | 60 | 6 | GO:0032609 | |
| GeneOntologyBiologicalProcess | thioester biosynthetic process | 1.24e-05 | 49 | 60 | 4 | GO:0035384 | |
| GeneOntologyBiologicalProcess | acyl-CoA biosynthetic process | 1.24e-05 | 49 | 60 | 4 | GO:0071616 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 1.28e-05 | 16 | 60 | 3 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 1.55e-05 | 17 | 60 | 3 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 1.55e-05 | 17 | 60 | 3 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 1.85e-05 | 18 | 60 | 3 | GO:0002428 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 2.98e-05 | 61 | 60 | 4 | GO:0032814 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 3.04e-05 | 124 | 60 | 5 | GO:0030101 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 3.39e-05 | 63 | 60 | 4 | GO:0043331 | |
| GeneOntologyBiologicalProcess | cellular response to exogenous dsRNA | 3.46e-05 | 22 | 60 | 3 | GO:0071360 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 3.98e-05 | 23 | 60 | 3 | GO:0019885 | |
| GeneOntologyBiologicalProcess | positive regulation of chondrocyte differentiation | 4.53e-05 | 24 | 60 | 3 | GO:0032332 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal stem cell differentiation | 4.97e-05 | 4 | 60 | 2 | GO:2000741 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 5.14e-05 | 25 | 60 | 3 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 5.14e-05 | 25 | 60 | 3 | GO:0002475 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 5.80e-05 | 142 | 60 | 5 | GO:0034032 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 5.80e-05 | 142 | 60 | 5 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 5.80e-05 | 142 | 60 | 5 | GO:0033875 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 6.39e-05 | 74 | 60 | 4 | GO:0002711 | |
| GeneOntologyBiologicalProcess | fatty-acyl-CoA biosynthetic process | 6.51e-05 | 27 | 60 | 3 | GO:0046949 | |
| GeneOntologyBiologicalProcess | positive regulation of response to tumor cell | 7.28e-05 | 28 | 60 | 3 | GO:0002836 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response to tumor cell | 7.28e-05 | 28 | 60 | 3 | GO:0002839 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 7.53e-05 | 150 | 60 | 5 | GO:0002824 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 9.92e-05 | 159 | 60 | 5 | GO:0002821 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 1.09e-04 | 32 | 60 | 3 | GO:0019883 | |
| GeneOntologyBiologicalProcess | malonyl-CoA metabolic process | 1.24e-04 | 6 | 60 | 2 | GO:2001293 | |
| GeneOntologyBiologicalProcess | somatic muscle development | 1.24e-04 | 6 | 60 | 2 | GO:0007525 | |
| GeneOntologyBiologicalProcess | pentose-phosphate shunt, non-oxidative branch | 1.24e-04 | 6 | 60 | 2 | GO:0009052 | |
| GeneOntologyBiologicalProcess | positive regulation of cartilage development | 1.56e-04 | 36 | 60 | 3 | GO:0061036 | |
| GeneOntologyBiologicalProcess | sulfur compound biosynthetic process | 1.68e-04 | 178 | 60 | 5 | GO:0044272 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated cytotoxicity | 2.14e-04 | 40 | 60 | 3 | GO:0045954 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 2.31e-04 | 41 | 60 | 3 | GO:0002474 | |
| GeneOntologyBiologicalProcess | fatty-acyl-CoA metabolic process | 2.48e-04 | 42 | 60 | 3 | GO:0035337 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 2.48e-04 | 42 | 60 | 3 | GO:0001916 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 2.48e-04 | 42 | 60 | 3 | GO:0043032 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated immunity | 2.85e-04 | 44 | 60 | 3 | GO:0002717 | |
| GeneOntologyBiologicalProcess | thioester metabolic process | 2.87e-04 | 109 | 60 | 4 | GO:0035383 | |
| GeneOntologyBiologicalProcess | acyl-CoA metabolic process | 2.87e-04 | 109 | 60 | 4 | GO:0006637 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 3.07e-04 | 111 | 60 | 4 | GO:0002709 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 3.92e-04 | 49 | 60 | 3 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 4.16e-04 | 50 | 60 | 3 | GO:0002834 | |
| GeneOntologyBiologicalProcess | lipid phosphorylation | 4.50e-04 | 11 | 60 | 2 | GO:0046834 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal stem cell differentiation | 4.50e-04 | 11 | 60 | 2 | GO:2000739 | |
| GeneOntologyBiologicalProcess | fatty acid derivative biosynthetic process | 4.67e-04 | 52 | 60 | 3 | GO:1901570 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 4.94e-04 | 53 | 60 | 3 | GO:0001914 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 5.51e-04 | 55 | 60 | 3 | GO:0043330 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide biosynthetic process | 5.69e-04 | 232 | 60 | 5 | GO:0009152 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 5.81e-04 | 56 | 60 | 3 | GO:0002418 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 6.03e-04 | 235 | 60 | 5 | GO:0002822 | |
| GeneOntologyBiologicalProcess | transition between fast and slow fiber | 6.36e-04 | 13 | 60 | 2 | GO:0014883 | |
| GeneOntologyBiologicalProcess | regulation of chondrocyte differentiation | 6.78e-04 | 59 | 60 | 3 | GO:0032330 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell differentiation | 7.40e-04 | 14 | 60 | 2 | GO:0072497 | |
| GeneOntologyBiologicalProcess | ribonucleotide biosynthetic process | 7.55e-04 | 247 | 60 | 5 | GO:0009260 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 8.26e-04 | 252 | 60 | 5 | GO:0002819 | |
| GeneOntologyBiologicalProcess | ribose phosphate biosynthetic process | 8.41e-04 | 253 | 60 | 5 | GO:0046390 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide biosynthetic process | 8.99e-04 | 65 | 60 | 3 | GO:0045429 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 9.55e-04 | 150 | 60 | 4 | GO:0002708 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide metabolic process | 9.82e-04 | 67 | 60 | 3 | GO:1904407 | |
| GeneOntologyBiologicalProcess | acylglycerol metabolic process | 1.10e-03 | 156 | 60 | 4 | GO:0006639 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 1.12e-03 | 70 | 60 | 3 | GO:0001913 | |
| GeneOntologyBiologicalProcess | neutral lipid metabolic process | 1.16e-03 | 158 | 60 | 4 | GO:0006638 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.16e-03 | 71 | 60 | 3 | GO:0002347 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 1.30e-03 | 163 | 60 | 4 | GO:0002456 | |
| GeneOntologyBiologicalProcess | purine nucleotide biosynthetic process | 1.32e-03 | 280 | 60 | 5 | GO:0006164 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 1.41e-03 | 76 | 60 | 3 | GO:0048002 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.41e-03 | 76 | 60 | 3 | GO:0042269 | |
| GeneOntologyBiologicalProcess | purine-containing compound biosynthetic process | 1.50e-03 | 288 | 60 | 5 | GO:0072522 | |
| GeneOntologyBiologicalProcess | positive regulation of cytokine production | 1.51e-03 | 586 | 60 | 7 | GO:0001819 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle adaptation | 1.53e-03 | 20 | 60 | 2 | GO:0014733 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 1.58e-03 | 79 | 60 | 3 | GO:0001912 | |
| GeneOntologyBiologicalProcess | amide biosynthetic process | 1.58e-03 | 172 | 60 | 4 | GO:0043604 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.64e-03 | 80 | 60 | 3 | GO:0002715 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 1.69e-03 | 175 | 60 | 4 | GO:0002705 | |
| GeneOntologyBiologicalProcess | regulation of cartilage development | 1.70e-03 | 81 | 60 | 3 | GO:0061035 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 1.70e-03 | 81 | 60 | 3 | GO:0043030 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 1.76e-03 | 82 | 60 | 3 | GO:1901568 | |
| GeneOntologyBiologicalProcess | glyceraldehyde-3-phosphate metabolic process | 1.85e-03 | 22 | 60 | 2 | GO:0019682 | |
| GeneOntologyBiologicalProcess | pentose-phosphate shunt | 1.85e-03 | 22 | 60 | 2 | GO:0006098 | |
| GeneOntologyBiologicalProcess | cartilage condensation | 2.02e-03 | 23 | 60 | 2 | GO:0001502 | |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | 2.06e-03 | 619 | 60 | 7 | GO:0006163 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 2.15e-03 | 88 | 60 | 3 | GO:0031343 | |
| GeneOntologyBiologicalProcess | fatty acid biosynthetic process | 2.32e-03 | 191 | 60 | 4 | GO:0006633 | |
| GeneOntologyBiologicalProcess | nucleotide biosynthetic process | 2.34e-03 | 319 | 60 | 5 | GO:0009165 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate biosynthetic process | 2.37e-03 | 320 | 60 | 5 | GO:1901293 | |
| GeneOntologyBiologicalProcess | NADPH regeneration | 2.39e-03 | 25 | 60 | 2 | GO:0006740 | |
| GeneOntologyBiologicalProcess | organophosphate biosynthetic process | 2.58e-03 | 644 | 60 | 7 | GO:0090407 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | 2.76e-03 | 652 | 60 | 7 | GO:0072521 | |
| GeneOntologyBiologicalProcess | cell aggregation | 2.79e-03 | 27 | 60 | 2 | GO:0098743 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell differentiation | 2.79e-03 | 27 | 60 | 2 | GO:2000738 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide biosynthetic process | 2.84e-03 | 97 | 60 | 3 | GO:0045428 | |
| Domain | Ribul_P_3_epim | 1.12e-05 | 2 | 63 | 2 | PF00834 | |
| Domain | RIBUL_P_3_EPIMER_1 | 1.12e-05 | 2 | 63 | 2 | PS01085 | |
| Domain | Ribul_P_3_epim | 1.12e-05 | 2 | 63 | 2 | IPR026019 | |
| Domain | Ribul_P_3_epim-like | 1.12e-05 | 2 | 63 | 2 | IPR000056 | |
| Domain | RibuloseP-bd_barrel | 3.35e-05 | 3 | 63 | 2 | IPR011060 | |
| Domain | MHC_I | 4.66e-05 | 21 | 63 | 3 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 4.66e-05 | 21 | 63 | 3 | IPR001039 | |
| Domain | - | 6.69e-05 | 4 | 63 | 2 | 3.90.1460.10 | |
| Domain | GTF2I | 6.69e-05 | 4 | 63 | 2 | PS51139 | |
| Domain | GTF2I | 6.69e-05 | 4 | 63 | 2 | PF02946 | |
| Domain | GTF2I | 6.69e-05 | 4 | 63 | 2 | IPR004212 | |
| Domain | - | 7.04e-05 | 24 | 63 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 7.04e-05 | 24 | 63 | 3 | IPR011161 | |
| Domain | MHC_I/II-like_Ag-recog | 2.84e-04 | 38 | 63 | 3 | IPR011162 | |
| Domain | DAGK_acc | 4.95e-04 | 10 | 63 | 2 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 4.95e-04 | 10 | 63 | 2 | IPR000756 | |
| Domain | DAGKa | 4.95e-04 | 10 | 63 | 2 | SM00045 | |
| Domain | DAGKc | 9.93e-04 | 14 | 63 | 2 | SM00046 | |
| Domain | IG_MHC | 1.09e-03 | 60 | 63 | 3 | PS00290 | |
| Domain | Diacylglycerol_kinase_cat_dom | 1.14e-03 | 15 | 63 | 2 | IPR001206 | |
| Domain | DAGK_cat | 1.14e-03 | 15 | 63 | 2 | PF00781 | |
| Domain | DAGK | 1.14e-03 | 15 | 63 | 2 | PS50146 | |
| Domain | NAD/diacylglycerol_kinase | 1.47e-03 | 17 | 63 | 2 | IPR016064 | |
| Domain | RNaseH-like_dom | 1.64e-03 | 69 | 63 | 3 | IPR012337 | |
| Domain | - | 2.26e-03 | 21 | 63 | 2 | 3.90.226.10 | |
| Domain | ClpP/crotonase-like_dom | 2.26e-03 | 21 | 63 | 2 | IPR029045 | |
| Domain | tRNA-bd_arm | 2.95e-03 | 24 | 63 | 2 | IPR010978 | |
| Domain | AMP-binding | 4.58e-03 | 30 | 63 | 2 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 4.58e-03 | 30 | 63 | 2 | IPR000873 | |
| Domain | Gal_Oxidase_b-propeller | 5.86e-03 | 34 | 63 | 2 | IPR015916 | |
| Domain | - | 8.84e-03 | 42 | 63 | 2 | 3.20.20.70 | |
| Domain | BTB-kelch_protein | 9.25e-03 | 43 | 63 | 2 | IPR017096 | |
| Domain | Aldolase_TIM | 9.67e-03 | 44 | 63 | 2 | IPR013785 | |
| Pubmed | 6.23e-09 | 3 | 65 | 3 | 25212604 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 12756263 | ||
| Pubmed | Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms. | 2.49e-08 | 4 | 65 | 3 | 20166740 | |
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 19081632 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 8882725 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 12421908 | ||
| Pubmed | MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation. | 6.21e-08 | 5 | 65 | 3 | 24572784 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 8982867 | ||
| Pubmed | Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D. | 1.24e-07 | 6 | 65 | 3 | 11825567 | |
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 20219610 | ||
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 10894171 | ||
| Pubmed | Polymorphisms of NKG2D ligands: diverse RAET1/ULBP genes in northeastern Thais. | 1.24e-07 | 6 | 65 | 3 | 19688209 | |
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 20976056 | ||
| Pubmed | Ligands for murine NKG2D display heterogeneous binding behavior. | 1.24e-07 | 6 | 65 | 3 | 11857333 | |
| Pubmed | The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. | 2.17e-07 | 7 | 65 | 3 | 16831899 | |
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 20870941 | ||
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 26151313 | ||
| Pubmed | NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis. | 2.17e-07 | 7 | 65 | 3 | 30787931 | |
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 12370332 | ||
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 25583577 | ||
| Pubmed | A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. | 3.47e-07 | 8 | 65 | 3 | 12645935 | |
| Pubmed | Gut microbiota regulates NKG2D ligand expression on intestinal epithelial cells. | 5.19e-07 | 9 | 65 | 3 | 23136011 | |
| Pubmed | Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. | 5.19e-07 | 9 | 65 | 3 | 14764662 | |
| Pubmed | A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. | 7.41e-07 | 10 | 65 | 3 | 11827464 | |
| Pubmed | Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles. | 1.02e-06 | 11 | 65 | 3 | 26656785 | |
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 3.44e-06 | 2 | 65 | 2 | 15388857 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 11585348 | ||
| Pubmed | Generation of mice harboring a Sox5 conditional null allele. | 3.44e-06 | 2 | 65 | 2 | 18543318 | |
| Pubmed | SoxD genes are required for adult neural stem cell activation. | 1.03e-05 | 3 | 65 | 2 | 35108528 | |
| Pubmed | Generation of mice harboring a Sox6 conditional null allele. | 1.03e-05 | 3 | 65 | 2 | 16652367 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 15100712 | ||
| Pubmed | Myocardial hypertrophy and the maturation of fatty acid oxidation in the newborn human heart. | 1.03e-05 | 3 | 65 | 2 | 18614968 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 15529345 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 7396409 | ||
| Pubmed | SOX trio decrease in the articular cartilage with the advancement of osteoarthritis. | 1.03e-05 | 3 | 65 | 2 | 21728837 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 26150426 | ||
| Pubmed | SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells. | 1.03e-05 | 3 | 65 | 2 | 28687615 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 21401405 | ||
| Pubmed | Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice. | 1.03e-05 | 3 | 65 | 2 | 17210641 | |
| Pubmed | 1.57e-05 | 26 | 65 | 3 | 23435420 | ||
| Pubmed | Dynamic epigenetic mechanisms regulate age-dependent SOX9 expression in mouse articular cartilage. | 2.06e-05 | 4 | 65 | 2 | 26806292 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 18559420 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 32960357 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 21328569 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 19759178 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 19424970 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 17823943 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 23229069 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 22899722 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 21262861 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 3.10e-05 | 861 | 65 | 9 | 36931259 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 19658097 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 20940257 | ||
| Pubmed | Acetyl-CoA carboxylase 1 is a suppressor of the adipocyte thermogenic program. | 3.43e-05 | 5 | 65 | 2 | 37163372 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 16627753 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 22547066 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 5360673 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 9755172 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 10207062 | ||
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 20181744 | ||
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 28559451 | ||
| Pubmed | Pairing SOX off: with partners in the regulation of embryonic development. | 7.18e-05 | 7 | 65 | 2 | 10729834 | |
| Pubmed | The transcription factor Sox5 modulates Sox10 function during melanocyte development. | 9.56e-05 | 8 | 65 | 2 | 18703590 | |
| Pubmed | Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. | 9.56e-05 | 8 | 65 | 2 | 19249008 | |
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 26345464 | ||
| Pubmed | A conserved family of genes related to the testis determining gene, SRY. | 9.56e-05 | 8 | 65 | 2 | 1614875 | |
| Pubmed | Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. | 1.23e-04 | 9 | 65 | 2 | 9150135 | |
| Pubmed | Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. | 1.23e-04 | 9 | 65 | 2 | 10944117 | |
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 28630873 | ||
| Pubmed | Translational Control of Sox9 RNA by mTORC1 Contributes to Skeletogenesis. | 1.23e-04 | 9 | 65 | 2 | 30008325 | |
| Pubmed | Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. | 1.53e-04 | 10 | 65 | 2 | 15096597 | |
| Pubmed | 1.53e-04 | 10 | 65 | 2 | 10037800 | ||
| Pubmed | 1.87e-04 | 11 | 65 | 2 | 16678811 | ||
| Pubmed | Restoration of synapse formation in Musk mutant mice expressing a Musk/Trk chimeric receptor. | 1.87e-04 | 11 | 65 | 2 | 12403715 | |
| Pubmed | Cloning of the genes encoding two murine and human cochlear unconventional type I myosins. | 1.87e-04 | 11 | 65 | 2 | 9119401 | |
| Pubmed | Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. | 1.87e-04 | 11 | 65 | 2 | 15781876 | |
| Pubmed | Hif-1alpha regulates differentiation of limb bud mesenchyme and joint development. | 1.87e-04 | 11 | 65 | 2 | 17470636 | |
| Pubmed | 1.87e-04 | 11 | 65 | 2 | 17021016 | ||
| Pubmed | 2.24e-04 | 12 | 65 | 2 | 26525805 | ||
| Pubmed | 2.24e-04 | 12 | 65 | 2 | 21945074 | ||
| Pubmed | 2.24e-04 | 12 | 65 | 2 | 34234180 | ||
| Pubmed | 2.65e-04 | 13 | 65 | 2 | 15634692 | ||
| Pubmed | 2.65e-04 | 13 | 65 | 2 | 22735158 | ||
| Pubmed | SOX2-LIN28/let-7 pathway regulates proliferation and neurogenesis in neural precursors. | 2.65e-04 | 13 | 65 | 2 | 23884650 | |
| Pubmed | 2.65e-04 | 13 | 65 | 2 | 27160681 | ||
| Pubmed | 3.08e-04 | 14 | 65 | 2 | 8921394 | ||
| Pubmed | 3.56e-04 | 15 | 65 | 2 | 14993235 | ||
| Pubmed | Cbfb2 Isoform Dominates More Potent Cbfb1 and Is Required for Skeletal Development. | 3.56e-04 | 15 | 65 | 2 | 26890219 | |
| Pubmed | 3.56e-04 | 15 | 65 | 2 | 20206616 | ||
| Pubmed | Identification of Genes With Enriched Expression in Early Developing Mouse Cone Photoreceptors. | 3.56e-04 | 15 | 65 | 2 | 31260032 | |
| Pubmed | Differential isoform expression and alternative splicing in sex determination in mice. | 3.56e-04 | 15 | 65 | 2 | 30871468 | |
| Pubmed | Misexpression of Sox9 in mouse limb bud mesenchyme induces polydactyly and rescues hypodactyly mice. | 4.06e-04 | 16 | 65 | 2 | 17222543 | |
| Pubmed | KLHL40 deficiency destabilizes thin filament proteins and promotes nemaline myopathy. | 4.06e-04 | 16 | 65 | 2 | 24960163 | |
| Pubmed | 4.06e-04 | 16 | 65 | 2 | 27760317 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 4.20e-04 | 1489 | 65 | 10 | 28611215 | |
| Pubmed | Spatio-temporal expression of Sox genes in murine palatogenesis. | 4.59e-04 | 17 | 65 | 2 | 27241892 | |
| Pubmed | Musculoskeletal integration at the wrist underlies the modular development of limb tendons. | 4.59e-04 | 17 | 65 | 2 | 26062940 | |
| Pubmed | Association analyses identify three susceptibility Loci for vitiligo in the Chinese Han population. | 4.59e-04 | 17 | 65 | 2 | 22951725 | |
| Pubmed | Cbfb regulates bone development by stabilizing Runx family proteins. | 4.59e-04 | 17 | 65 | 2 | 25262822 | |
| Pubmed | 5.16e-04 | 18 | 65 | 2 | 29899135 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q25 | 8.97e-05 | 164 | 65 | 4 | chr6q25 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 1.62e-04 | 10 | 35 | 2 | 1178 | |
| GeneFamily | SRY-boxes | 6.10e-04 | 19 | 35 | 2 | 757 | |
| GeneFamily | Kelch like|BTB domain containing | 2.99e-03 | 42 | 35 | 2 | 617 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 4.04e-03 | 49 | 35 | 2 | 584 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 5.08e-05 | 778 | 59 | 10 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | 6.09e-05 | 795 | 59 | 10 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.36e-04 | 36 | 59 | 3 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.36e-04 | 36 | 59 | 3 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | 1.41e-04 | 880 | 59 | 10 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_500_k-means-cluster#2 | 1.73e-04 | 39 | 59 | 3 | ratio_SC_vs_MESO_500_K2 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 1.80e-04 | 101 | 59 | 4 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 2.71e-04 | 776 | 59 | 9 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.18e-04 | 333 | 59 | 6 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 3.24e-04 | 795 | 59 | 9 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | 3.36e-04 | 799 | 59 | 9 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | 3.71e-04 | 810 | 59 | 9 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.86e-04 | 51 | 59 | 3 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | 4.06e-04 | 820 | 59 | 9 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 | |
| ToppCell | 21-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 3.31e-07 | 188 | 65 | 6 | e78d4f7a5d28c77503cb041ff585d13df4c88bd2 | |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 3.63e-07 | 191 | 65 | 6 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Pulmonary_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.59e-06 | 180 | 65 | 5 | 57689ccbbd44c0e78e061edd87d3102c5f2dcc9a | |
| ToppCell | facs-Marrow-T-cells-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-06 | 185 | 65 | 5 | e1fd0a807def8c2127194108b1a30c6de7024292 | |
| ToppCell | 18-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 7.53e-06 | 185 | 65 | 5 | f8fc7b12b4e18d23d84e95488be93c4352d325f3 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-06 | 186 | 65 | 5 | 4dce1484653bb266e2305cbb306fb11eaf7892e2 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-06 | 186 | 65 | 5 | e23e1246914e230369a716d0d666b98383bf8512 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.14e-06 | 188 | 65 | 5 | 1f912ea015f50570e848259d948a0ba682d64bb4 | |
| ToppCell | 18-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 8.35e-06 | 189 | 65 | 5 | 144beb01b908f2cd0e04513fb84d817e0c3c124e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.57e-06 | 190 | 65 | 5 | 40d8b3403f4e38436b961cd3a2e69826cbae3042 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.57e-06 | 190 | 65 | 5 | f6cbf6d292f488ada5f7581e1dceba6198b933d1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.57e-06 | 190 | 65 | 5 | a9a705455019e28d655636de73b07540798f82e6 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 199 | 65 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.04e-05 | 151 | 65 | 4 | d19fc363ba1d7ff77e0adcaacafa4c64e1143f40 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 166 | 65 | 4 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 166 | 65 | 4 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 168 | 65 | 4 | 110c3c7c322e04a684a19c2b5434a502279fd000 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 168 | 65 | 4 | 735d30cfda1889740bdeb43e39330a52e8f4d599 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.09e-04 | 169 | 65 | 4 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-04 | 171 | 65 | 4 | a8adce007ff4c713f71f2359b40cb3575b28c98d | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 171 | 65 | 4 | 8719a18c9e6b6f5d8ec4e937c2bda1e36441c9ec | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 171 | 65 | 4 | b7cddb8f726a43fb8a37f3e67a3f722e2178fd7a | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 171 | 65 | 4 | f4cdd7862c8fe99ee765a2f3ed375b584f4976c5 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 173 | 65 | 4 | b6bb2a136a40f0946bbcde8d5972d3f059d080c7 | |
| ToppCell | facs-Marrow-T-cells|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 173 | 65 | 4 | 806f94f5c3ac836ddffc389d3c2cd7e4da7a608d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-04 | 174 | 65 | 4 | 59ccc5a82507463e0a316ba6286cb25ec1a4091b | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 174 | 65 | 4 | 919fc124affc69acfd8f575f2c372674f3d2625e | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-04 | 175 | 65 | 4 | 3bdccb4037053795d62ab5b6fcc09cdd406f9b50 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-regulatory_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-04 | 175 | 65 | 4 | 770546ddaa49ee482c4c7577ab76efbc6c304a29 | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.27e-04 | 176 | 65 | 4 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 177 | 65 | 4 | dba8b30a311051c22ca5f77697f5dbf9423c3ba0 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 177 | 65 | 4 | 6561794ae3b14b5279b249eb5e93b80ef15ed82c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 180 | 65 | 4 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 180 | 65 | 4 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 1.45e-04 | 182 | 65 | 4 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.57e-04 | 186 | 65 | 4 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Pulmonary_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.57e-04 | 186 | 65 | 4 | fcabebdfbf1b1dbb35ce2b3c53a60d2b1aed8e6c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.57e-04 | 186 | 65 | 4 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-04 | 188 | 65 | 4 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-PNEC-PNEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.74e-04 | 191 | 65 | 4 | 146cfd4daa2878536b4f381564c787919ad855a8 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-PNEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.74e-04 | 191 | 65 | 4 | 12ea07565dc0e62cade9fbab4a2d763e47a341e3 | |
| ToppCell | control-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.74e-04 | 191 | 65 | 4 | afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 1.78e-04 | 192 | 65 | 4 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.78e-04 | 192 | 65 | 4 | 24797e80b1f5b3ea5a0410caaf57ccf2ae9d716e | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.81e-04 | 193 | 65 | 4 | 25b1e5a04724023918c8939109a92b35582d5e5c | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.85e-04 | 194 | 65 | 4 | b8f05efb16fbed7317019efc3da7f97f81e90972 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 1.85e-04 | 194 | 65 | 4 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 1.85e-04 | 194 | 65 | 4 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-04 | 194 | 65 | 4 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.85e-04 | 194 | 65 | 4 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.88e-04 | 195 | 65 | 4 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.88e-04 | 195 | 65 | 4 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.88e-04 | 195 | 65 | 4 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.96e-04 | 197 | 65 | 4 | 3a0e97bfebe82f9687d518baaad7f20d0ffea8a1 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 2.00e-04 | 198 | 65 | 4 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 198 | 65 | 4 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-04 | 198 | 65 | 4 | 40c2171e79f578c9116d872c189f953dc61d052d | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-NK_CD56bright|Influenza_Severe / Disease, condition lineage and cell class | 2.04e-04 | 199 | 65 | 4 | 784e7e7ede2baa28ede600834813e6de2240bfdf | |
| Disease | level of UL16-binding protein 6 in blood serum | 4.63e-06 | 2 | 64 | 2 | OBA_2043185 | |
| Disease | hematocrit | 6.03e-05 | 1011 | 64 | 10 | EFO_0004348 | |
| Disease | Anorectal Malformations | 9.78e-05 | 41 | 64 | 3 | C3495676 | |
| Disease | AUTISM, SUSCEPTIBILITY TO, 15 | 1.29e-04 | 8 | 64 | 2 | C2677504 | |
| Disease | amino acid measurement | 6.55e-04 | 678 | 64 | 7 | EFO_0005134 | |
| Disease | C-reactive protein measurement | 1.13e-03 | 1206 | 64 | 9 | EFO_0004458 | |
| Disease | lymphocyte count | TYK2 JCAD GTF2IRD2B THRB ACACA ACSBG1 AHNAK GTF2IRD2 DGKD ZNF295-AS1 | 1.15e-03 | 1464 | 64 | 10 | EFO_0004587 |
| Disease | multisite chronic pain | 1.17e-03 | 95 | 64 | 3 | EFO_0010100 | |
| Disease | free androgen index | 1.32e-03 | 374 | 64 | 5 | EFO_0007005 | |
| Disease | alkaline phosphatase measurement | 1.53e-03 | 1015 | 64 | 8 | EFO_0004533 | |
| Disease | R-6-hydroxywarfarin to R-warfarin ratio measurement | 1.60e-03 | 106 | 64 | 3 | EFO_0803333 | |
| Disease | testosterone measurement | 1.65e-03 | 1275 | 64 | 9 | EFO_0004908 | |
| Disease | peptide measurement | 1.73e-03 | 109 | 64 | 3 | EFO_0010520 | |
| Disease | Severe Congenital Microcephaly | 2.07e-03 | 31 | 64 | 2 | C3853041 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGMDPKAKQHMWRAI | 1461 | Q8WWZ7 | |
| KEMQRWIMEKTAEHF | 121 | Q9BRK5 | |
| PIHDKWEMERTDITM | 276 | P42684 | |
| WEMERTDITMKHKLG | 281 | P42684 | |
| MHWVVRGKKDLMLEE | 101 | Q9UKB3 | |
| EIGMVAWKMTFKSPE | 1656 | Q13085 | |
| VEVHDPDWHLKMPKM | 1701 | Q09666 | |
| RPVVWHGMAMVKALS | 3851 | Q96M86 | |
| MTVPKEMPEKWARAQ | 1 | P98198 | |
| TMPVSLLKAHEAEMW | 251 | Q8NFH3 | |
| HKPIWMHAEEREEMS | 421 | Q9NSK0 | |
| TKHPHIKMVMESGDW | 351 | O95340 | |
| EMRIMTPEGKWHASK | 266 | Q13478 | |
| EHVMKKPVWEEELRM | 161 | Q9P266 | |
| HAERTWMEKMKVEDL | 31 | Q8NHP7 | |
| EAVHPVKNWMDMKRR | 216 | O95822 | |
| KTVMEGWVKVMVPEA | 151 | P86397 | |
| LKDLEMSKVVHMDRW | 486 | P23743 | |
| KVALVKCRDLHWAMM | 606 | Q9P265 | |
| VSMRRAPLMWELIHK | 366 | A6NJ78 | |
| SMKVWLLEHMKCEII | 671 | Q8NB91 | |
| EHVVAASKAMKMGDW | 736 | B5ME19 | |
| HMAEPVTFWVRVKMD | 541 | Q14674 | |
| PRAEMRPVKHKWTMI | 461 | Q6WRI0 | |
| MWMTPKRSKMEVDEA | 1 | Q7L775 | |
| KVHMKDVMSALWVSG | 211 | Q9H2C0 | |
| MDARRKHWKENMFTP | 1 | A6NGH7 | |
| SHMGVPRVWEKIMER | 371 | Q96GR2 | |
| IQAMKPMTKEEWDAR | 166 | Q66PJ3 | |
| KEKVDLVLMHWRDRM | 716 | O75165 | |
| EHPEKCRSRTKNMMW | 786 | Q16760 | |
| EWVRLHDKMKVDMSG | 946 | A2RUR9 | |
| KMDHVMDVVVKSVNW | 666 | Q86UP8 | |
| KMDHVMDVVVKSVNW | 666 | Q6EKJ0 | |
| DWEDIKKMPEHSTLM | 266 | P49336 | |
| MESKTEKWMERIHLN | 121 | P20273 | |
| MKLWMESHLIVPETR | 1 | Q8NGR1 | |
| ILHWQVKDVMKDVMS | 131 | P46939 | |
| EMGKHDEAWMILKQV | 306 | Q7L1I2 | |
| HVPREMAAETSKWLM | 1221 | Q96ST3 | |
| KAHSDTWMVVLDPMK | 76 | Q9HAT2 | |
| IKRPMNAFMVWAKDE | 621 | P35712 | |
| PRKIIRMWAEKEMHN | 321 | O14730 | |
| TMHLSVWEKPMDLKD | 361 | Q5VWI1 | |
| KEPWNMKRHEMVDEP | 91 | Q8TF32 | |
| HIWKKIMHTDAMIID | 1066 | P10745 | |
| QPFWRKEMEIMADSK | 351 | Q9Y5K1 | |
| KFMEDMMPKVHWLRT | 151 | Q2QD12 | |
| HFWPKLLMKVTDLRM | 416 | P10828 | |
| WKGHEFSIPFVEMKM | 1326 | Q92752 | |
| RMWTTVHPGARKMKE | 156 | Q6H3X3 | |
| HSAVWVPMMKEKASH | 216 | Q6UXR4 | |
| RMWTTVHPGARKMKE | 156 | Q5VY80 | |
| RFNHPAEAKWMKSMI | 131 | Q86UU1 | |
| KAPMVIMDWEECSKM | 211 | Q6UWB4 | |
| EAWSMKRHEIMVAKP | 61 | Q03923 | |
| IKRPMNAFMVWAKDE | 556 | P35711 | |
| QPMIDHLVTMKISHW | 561 | Q9BTW9 | |
| MKDKMWCEDTAQPHR | 1 | Q8N0V1 | |
| RMWTTVHPGARKMKE | 156 | Q9BZM5 | |
| KFMEDMMPKVHWLRT | 151 | Q96AT9 | |
| VMRWLCKHENPKMQT | 471 | Q6WRX3 | |
| RERGHVPMAWKMVVA | 701 | P29597 | |
| PWHMKKAFKVMNELR | 36 | O95198 | |
| IRDDPKMMWSMHVAK | 2811 | P20929 | |
| KDDPKMMWSIHVAKI | 3541 | P20929 | |
| AMVKMAKDWKTVPER | 451 | P16519 |